Trends over time in the incidence of cervical neoplasia in comparison to trends over time in human papillomavirus infection (Q34089060)

30 July 2017

title

Trends over time in the incidence of cervical neoplasia in comparison to trends over time in human papillomavirus infection (English)

1 reference

Papillomavirus infections

30 July 2017

main subject

1 reference

Dillner J

1

1 reference

30 July 2017

publication date

1 October 2000

1 reference

Journal of Clinical Virology

30 July 2017

published in

1 reference

30 July 2017

volume

19

1 reference

30 July 2017

issue

1-2

1 reference

30 July 2017

page(s)

7-23

1 reference

publication type of scholarly work

30 July 2017

review article

1 reference

Stability over Time of Serum Antibody Levels to Human Papillomavirus Type 16

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Trends in seroprevalence of human papillomavirus type 16 among pregnant women in Stockholm, Sweden, during 1969–1989

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

A survey of seroprevalence of human papillomavirus types 16, 18 and 33 among children

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

No serological evidence for non-sexual spread of HPV16

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

A prospective study on the risk of cervical intra-epithelial neoplasia among healthy subjects with serum antibodies to HPV compared with HPV DNA in cervical smears

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Antigenic and immunogenic epitopes shared by human papillomavirus type 16 and bovine, canine, and avian papillomaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

The serological response to papillomaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Sero-epidemiologal association between human-papillomavirus infection and risk of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

High risk genital papillomavirus infections are not spread vertically

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Human papillomavirus infection is transient in young women: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

The Sexually Transmitted Disease Model for Cervical Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Transmission of Cervical Human Papillomavirus Infection by Sexual Activity: Differences between Low and High Oncogenic Risk Types

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Epidemiology of Acquisition and Clearance of Cervical Human Papillomavirus Infection in Women from a High‐Risk Area for Cervical Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Association of serum immunoglobulin G antibodies against human papillomavirus type 16 capsids with anal epidermoid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Determinants of genital human papillomavirus infection in low-income women in Washington, D.C.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Persistence of type-specific human papillomavirus infection among cytologically normal women

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Natural History of Cervicovaginal Papillomavirus Infection in Young Women

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Cell-mediated immune responses to E7 peptides of human papillomavirus (HPV) type 16 are dependent on the HPV type infecting the cervix whereas serological reactivity is not type-specific

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Attack rates of human papillomavirus type 16 and cervical neoplasia in primiparous women and field trial designs for HPV16 vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Human papillomavirus, herpes simplex virus and other potential risk factors for cervical cancer in a high-risk area (Greenland) and a low-risk area (Denmark)--a second look.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Sexual behaviour and papillomavirus exposure in cervical intraepithelial neoplasia: a population-based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Identification of a cytotoxic T-lymphocyte epitope in the human papillomavirus type 16 E2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Chlamydia trachomatis infection as a risk factor for invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Human T helper cell epitopes overlap B cell and putative cytotoxic T cell epitopes in the E2 protein of human papillomavirus type 16.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Vaccination against colonizing bacteria with multiple serotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Detection of Human Papillomavirus Type 16 DNA and of Antibodies to Human Papillomavirus Type 16 Proteins in Children

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Seroreactivity to HPV16 virus-like particles as a marker for cervical cancer risk in high-risk populations

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

A population-based case-control study of human papillomavirus-type-16 seropositivity and incident high-grade dysplasia of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

The impact of screening on the incidence of cervical cancer in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Has screening for cervical cancer been successful?

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Risk factors for genital papillomavirus infection in populations at high and low risk for cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Papillomavirus Is Resistant to Desiccation

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Serological evidence for protection by human papillomavirus (HPV) type 6 infection against HPV type 16 cervical carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Effect of smoking cessation on cervical lesion size

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

A monoclonal antibody against intact human papillomavirus type 16 capsids blocks the serological reactivity of most human sera

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Type specificity and significance of different isotypes of serum antibodies to human papillomavirus capsids

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Evaluation of Seroreactivity to Human Papillomavirus Type 16 Virus-like Particles in an Incident Case-Control Study of Cervical Neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Epidemiologic determinants of seroreactivity to human papillomavirus (HPV) type 16 virus-like particles in cervical HPV-16 DNA-positive and-negative women

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

International trends in incidence of cervical cancer: II. Squamous-cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Identification of human papillomavirus seroconversions

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Prospective study on the development of antibodies against human papillomavirus type 6 among patients with condyloma acuminata or new asymptomatic infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Smoking and oral contraceptives as risk factors for cervical carcinoma in situ

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

10.1016/S1386-6532(00)00126-8

Identifiers

DOI

1 reference

30 July 2017

1 reference